Research-stage cardiac regeneration programs and an open measurement stack.
Company intro · ~1:20
Builds Virelion’s cardiac programs and the open research stack around HeartTwin , measurement, simulation, and evaluation for regenerative cardiology.
Focus: VB-101 / VB-204 discovery framing · HeartTwin platform · public tool validation
virelion85@gmail.com · GitHub
VB-101 gene therapy (candidate identification), VB-204 engineered grafts (discovery), and VB-310 HeartTwin (active platform development). Shared open-source engines for imaging, ECG, mechanics, and safety scoring.
Architecture release for the modular stack , research framework documentation, not clinical validation.
No public patents listed yet. Filings will appear here with jurisdiction, number, and status when available.
2024 Virelion founded; VB-101 discovery begins.
2025 VB-204 engineered graft program enters discovery.
2026 Public org grows to 20+ repositories; HeartTwin active development; first Zenodo architecture release.
Engineering the heart. Blood red #5c0a14, Newsreader + Inter, lion-brain mark. Full kit on the press page.
